Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Support your weight loss goals now
Research suggests that the medication, a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, originally developed to manage type 2 diabetes, may be able to treat a wide range of conditions involving impulse control, like binge eating disorder
The Cagri-Reta combination extrapolates this concept further by replacing Semaglutide with the far more potent Retatrutide
It promotes the formation of blood vessels via a process known as angiogenesis, and upregulates vascular endothelial growth factor (VEGF), a protein that stimulates blood vessel growth
5mg per vial Primary Benefits Activates tissue remodeling genes and enhances collagen production
US$ 22.78
US$ 22.77
US$ 23.23
US$ 28.24
